Insider Stock Trading History of Shafer Bradford J


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Shafer Bradford J since year 2005. The trader's CIK number is 1302448. At the time of this reporting, Shafer Bradford J is the EVP, Gen. Counsel, Secretary of Theravance Biopharma, Inc. . (stock ticker symbol TBPH). See this page for all insider trading activities at Theravance Biopharma, Inc. .

Note that in the past Shafer Bradford J also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Shafer Bradford J since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-09-06 TBPH Theravance Biopharma, Inc. Sale 14,670 30.77 451,351
2017-03-03 TBPH Theravance Biopharma, Inc. Sale 26,829 31.86 854,771
2016-08-18 TBPH Theravance Biopharma, Inc. Sale 7,174 28.55 204,817
2016-08-19 TBPH Theravance Biopharma, Inc. Sale 4,870 28.14 137,041
2016-08-22 TBPH Theravance Biopharma, Inc. Sale 37,078 27.16 1,007,038
2014-08-12 THRX Theravance Inc Sale 1,048 22.30 23,370
2014-08-11 THRX Theravance Inc Sale 27,108 22.12 599,628
2014-08-11 THRX Theravance Inc Option Ex 33,667 14.53 489,181
2014-03-03 THRX Theravance Inc Option Ex 96,773 9.69 937,536
2014-03-03 THRX Theravance Inc Sale 65,806 36.98 2,433,176
2013-06-07 THRX Theravance Inc Sale 31,038 35.04 1,087,571
2011-11-28 THRX Theravance Inc Option Ex 30,205 8.53 257,648
2011-11-28 THRX Theravance Inc Sale 20,000 21.00 420,000
2011-03-11 THRX Theravance Inc Sale 26,689 22.75 607,308
2008-07-30 THRX Theravance Inc Sale 34,676 15.97 553,671
2007-10-31 THRX Theravance Inc Sale 25,000 25.00 625,000
2007-08-01 THRX Theravance Inc Sale 7,300 26.40 192,705
2007-08-01 THRX Theravance Inc Sale 16,200 25.86 418,996
2007-08-01 THRX Theravance Inc Sale 1,500 25.64 38,452
2006-05-03 THRX Theravance Inc Option Ex 40,761 5.81 236,902

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Shafer Bradford J (EVP, Gen. Counsel, Secretary of Theravance Biopharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.